Compare SPGI & SYK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | SPGI | SYK |
|---|---|---|
| Founded | 1860 | 1941 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance: Consumer Services | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 150.5B | 141.2B |
| IPO Year | N/A | N/A |
| Metric | SPGI | SYK |
|---|---|---|
| Price | $497.85 | $363.34 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 13 | 15 |
| Target Price | ★ $609.31 | $434.64 |
| AVG Volume (30 Days) | 1.5M | ★ 1.7M |
| Earning Date | 10-30-2025 | 10-30-2025 |
| Dividend Yield | 0.77% | ★ 0.92% |
| EPS Growth | ★ 21.42 | N/A |
| EPS | ★ 13.74 | 7.61 |
| Revenue | $15,012,000,000.00 | ★ $24,381,000,000.00 |
| Revenue This Year | $9.85 | $12.01 |
| Revenue Next Year | $7.21 | $8.59 |
| P/E Ratio | ★ $36.28 | $47.83 |
| Revenue Growth | 9.04 | ★ 10.95 |
| 52 Week Low | $427.14 | $329.16 |
| 52 Week High | $579.05 | $406.19 |
| Indicator | SPGI | SYK |
|---|---|---|
| Relative Strength Index (RSI) | 53.01 | 45.54 |
| Support Level | $490.81 | $364.49 |
| Resistance Level | $502.10 | $374.10 |
| Average True Range (ATR) | 6.77 | 6.22 |
| MACD | 0.55 | 0.03 |
| Stochastic Oscillator | 73.15 | 30.67 |
S&P Global provides data and benchmarks to capital and commodity market participants. Its ratings business is the largest credit rating agency in the world and S&P's largest segment by profitability. S&P's largest segment by revenue is market intelligence, which provides desktop, data and advisory solutions, enterprise solutions, and credit/risk solutions mostly in the financial-services industry. S&P's other segments include commodity insights (Platts and other data), mobility (Carfax), and indexes.
Stryker designs, manufactures, and markets an array of medical equipment, instruments, consumable supplies, and implantable devices. The product portfolio includes hip and knee replacements, extremities, endoscopy systems, operating room equipment, embolic coils, hospital beds and gurneys, and orthopedic robotics. Stryker remains one of the three largest competitors in reconstructive orthopedic implants and holds the leadership position in operating room equipment. Roughly one-fourth of Stryker's total revenue currently comes from outside the United States.